MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 17, 2008; DOI: 10.1124/mol.107.043067


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.043067v1
73/4/1185    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Tooraj Mirshahi
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, C.
Right arrow Articles by Zhang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, C.
Right arrow Articles by Zhang, H.


Received for publication October 31, 2007.
Revised January 9, 2008.
Accepted for publication January 15, 2008.

ARACHIDONIC ACID ACTIVATES KIR2.3 CHANNELS BY ENHANCING CHANNEL-PIP2 INTERACTIONS

Chuan Wang 1, Uyenlinh L Mirshahi 1, Boyi Liu 2, Zhanfeng Jia 2, Tooraj Mirshahi 1*, Hailin Zhang 2

1 Geisinger Clinic 2 Hebei Medical University

* Address correspondence to: E-mail: tmirshahi{at}geisinger.edu

Abstract

Kir2.0 channels play a significant role in setting the resting membrane potential, modulating action potential waveform, and buffering extracellular potassium. One member of this family, Kir2.3, is highly expressed in the heart and brain and is modulated by a variety of factors including arachidonic acid (AA). Using two electrode voltage clamp and inside-out patch clamp recordings from Xenopus oocytes expressing Kir2.3 channels we find that AA selectively activates Kir2.3 channels with an EC50 of 0.59 µM and this activation requires Phosphatidyl-inositol(4,5) bis-phosphate (PIP2). We find that AA activates Kir2.3 by enhancing channel-PIP2 interactions as demonstrated by a shift in PIP2 activation curve. EC50 for channel activation by PIP2 are 36 and 12 µM in the absence and presence of AA respectively. A single point mutation on the channel C-terminus that enhanced basal channel-PIP2 interactions reduced the sensitivity of the channel to AA. Effects of AA are mediated through cytoplasmic sites on the channel by increasing the open probability mainly due to more frequent bursts of opening in the presence of PIP2. Therefore, enhanced interaction with PIP2 is the molecular mechanism for Kir2.3 channel activation by AA.


Key words: Ion channel regulation, Potassium, Phospholipase C's, Phospholipase A2's, IP3/DAG, Func. analysis receptor/ion channel mutants, Mutagenesis/Chimeric approaches, Single channel kinetics, Oxidative stress, Ischemia/Reperfusion





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics